PUNE, India, May 22, 2018 /PRNewswire/ --
According to a new market research report "Patient Monitoring Device/System/Equipment Market by Product (EEG, EMG, MEG, TCD, Peak Flow Meter, Pulse Oximeter, Fetal Monitoring, Temperature Monitoring Devices, MCOT, ECG, Hemodynamic Monitoring System), End User (Home, Hospital) - Global Forecast to 2023", published by MarketsandMarkets™, the market is projected to reach USD 25.31 Billion by 2023 from USD 19.14 Billion in 2018, at a CAGR of 5.7%. Factors such as the easy availability of wireless monitoring devices and the rising incidence of lifestyle and chronic diseases are expected to drive market growth during the forecast period. The growing demand for patient monitoring devices in non-hospital settings is also expected to provide a range of growth opportunities for players in the market. On the other hand, the risks associated with invasive monitoring devices are expected to challenge market growth to a certain extent in the coming years.
Browse 106 market data Tables and 32 Figures spread through 150 Pages and in-depth TOC on "Patient Monitoring Device/System/Equipment Market"
Early buyers will receive 10% customization on this report
The ECG segment is expected to account for the largest share of the cardiac monitoring devices market in 2018
By product, the cardiac monitoring devices market is classified into ECG devices, IRLs, event monitors, MCT monitors, and smart wearable ECG monitors. In 2018, the ECG devices segment is expected to account for the largest share of the market. The large share of this segment can primarily be attributed to the increasing incidence of cardiovascular diseases, the wide application of ECG devices in CVD management, the development of technologically advanced devices, and government initiatives.
The cerebral oximeter segment is expected to grow at the highest CAGR in neuromonitoring devices market during the forecast period
By product, the neuromonitoring devices market is divided into EEG machines, cerebral oximeters, EMG machines, ICP monitors, MEG machines, and TCD machines. In 2018, the cerebral oximeters segment is expected to grow at the highest CAGR during the forecast period. Cerebral oximeters offer real-time data to physicians through a noninvasive procedure. This is a major factor driving the growth of this market. The real-time data obtained is useful to make emergency care decisions and observe the effects of interventions.
Ask for PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=678
The pulse oximeters segment is expected to account for the largest share of the respiratory monitoring devices market in 2018
By product, the respiratory monitoring devices market includes pulse oximeters, spirometers, capnographs, and peak flow meters. In 2018, the ECG devices segment is expected to account for the largest share of the market. The development of innovative products such as fingertip pulse oximeters, pulse oximeter sensors, and Bluetooth-enabled pulse oximeters-and their growing uptake are the key factors driving the growth of the pulse oximeters market.
Asia is expected to grow at the highest CAGR during the forecast period
On the basis of region, the Patient Monitoring Devices Market is segmented into North America, Europe, Asia, and RoW. Asia is expected to grow at the highest CAGR during the forecast period. Factors such as the increasing per capita healthcare expenditure, growing public health awareness, rising prevalence of lifestyle diseases, and improving treatment rates in emerging markets across India and China are expected to drive growth in the market in this region.
The Patient Monitoring Devices Market is dominated by players such as Medtronic (Ireland), Abbott (US), Natus Medical (US), Nihon Kohden (Japan), GE Healthcare (US), and Philips Healthcare (Netherlands).
Know more about the Patient Monitoring Device/System/Equipment Market:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
630 Dundee Road
Northbrook, IL 60062
Connect with us on LinkedIn: http://www.linkedin.com/company/marketsandmarkets